<?xml version="1.0" encoding="UTF-8"?>
<p class="p">Forty subjects were randomized based on the inclusion and exclusion criteria. There were six dropouts: one due to health reasons, four due to personal reasons and one excluded because subsequently submitted to a drug therapy. In total, 34 subjects completed the trial (17 each group, see 
 <xref ref-type="fig" rid="F1" class="xref">Figure 1</xref>). 
 <xref rid="T1" ref-type="table" class="xref">Table 1</xref> presents demographic data of the study population. There were no significant differences in mean age, sex and smoke of individuals between the two groups. At T0, there were no statistical differences in FMBS between the CG and TG; both groups showed a significant reduction in FMBS from T0 to T1. At T1, the TG group showed a statistically significant decrease in FMBS (
 <italic class="italic">p</italic> = 0.002) compared with the CG group (
 <xref rid="T2" ref-type="table" class="xref">Table 2</xref>).
</p>
